skip to content »

Neurology

Houston, Texas

The Cullen Building at Baylor College of Medicine.
Department of Neurology
not shown on screen

Susan Rountree, M.D.

Assistant Professor of Neurology

Clinical Service Area

Neurology

Specialty

Alzheimer's Disease
Memory Disorders
General Neurology

Board Certification

American Board of Psychiatry and Neurology, Neurology

Clinic Appointments

713-798-4734

Consult

713-798-4734

Medical School

M.D., University of Arkansas for Medical Sciences College of Medicine, Little Rock, Ark.

Internship

Internal Medicine, Regions Hospital, St. Paul, Minn.
Internal Medicine, University of Arkansas for Medical Sciences College of Medicine, Little Rock, Ark.

Residency

Neurology, University of Arkansas for Medical Sciences College of Medicine, Little Rock, Ark.
Neurology, Baylor College of Medicine, Houston, Texas

Clinic Location

Baylor Neurology
The Medical Building
1977 Butler Blvd., Suite E5.101
Houston, Texas 77030

Clinical Interests

Alzheimer's disease, memory loss, mild cognitive impairment

Contact Information

Susan Rountree, M.D.
Department of Neurology
Baylor College of Medicine
1977 Butler Blvd., Suite E5.101
Houston, Texas 77030

Tel: 713-798-4734
Fax: 713-798-5326
Email:

Journal Publications (Selected out of 11)

  • Rountree SD, Atri A, Lopez OL, Doody RS. Effectiveness of antidementia drugs in delaying Alzheimer's disease progression. Alzheimers Dement. 2013;9(3):338-45. [View journal article]
  • Atri A, Rountree SD, Lopez OL, Doody RS. Validity, significance, strengths, limitations, and evidentiary value of real-world clinical data for combination therapy in Alzheimer's disease: comparison of efficacy and effectiveness studies. Neurodegener Dis. 2012;10(1-4):170-4. [View journal article]
  • Rountree SD, Chan W, Pavlik VN, Darby EJ, Doody RS. Factors that influence survival in a probable Alzheimer disease cohort. Alzheimers Res Ther. 2012;4(3):16. [View journal article]
  • Doody RS, Pavlik V, Massman P, Rountree S, Darby E, Chan W. Correction: Predicting progression of Alzheimer's disease. Alzheimers Res Ther. 2010;2(3):14. [View journal article]
  • Doody RS, Pavlik V, Massman P, Rountree S, Darby E, Chan W. Predicting progression of Alzheimer's disease. Alzheimers Res Ther. 2010;2(1):2. [View journal article]
  • Pavlik VN, Doody RS, Rountree SD, Darby EJ. Vitamin E use is associated with improved survival in an Alzheimer's disease cohort. Dement Geriatr Cogn Disord. 2009;28(6):536-40. [View journal article]
  • Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Doody RS. Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease. Alzheimers Res Ther. 2009;1(2):7. [View journal article]
  • Sitburana O, Rountree S, Ondo WG. Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs. J Neurol Sci. 2008;272(1-2):77-82. [View journal article]
  • Yan JH, Rountree S, Massman P, Doody RS, Li H. Alzheimer's disease and mild cognitive impairment deteriorate fine movement control. J Psychiatr Res. 2008;42(14):1203-12. [View journal article]
  • Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS. Is functional decline necessary for a diagnosis of Alzheimer's disease? Dement Geriatr Cogn Disord. 2007;24(5):375-9. [View journal article]

Book Chapters and Other Publications

  • Rountree S, Cummings J. Current management of Alzheimer's disease. In: Doody RS, editor. Alzheimer's dementia. Delray Beach (FLA): Carma Publishing; 2008. p. 45-95.

Poster and Platform Presentations (Selected out of 14)

  • Doody R, Chan W, Pavlik V, Rountree S, Massman P. Premorbid IQ and intrinsic progression rate explain substantial variance in observed progression of Alzheimer's disease (AD) on multiple measures. Presented at the Alzheimer's Association International Conference (AAIC), Annual Meeting in Vancouver, British Columbia, Canada (July 14-19, 2012).
  • Rountree S, Chan W, Pavlik V, Doody R. Factors that influence long term care placement in an Alzheimer disease cohort. Presented at the Alzheimer's Association International Conference (AAIC), Annual Meeting in Vancouver, British Columbia, Canada (July 14-19, 2012). [View poster]
  • Rountree S, Chan W, Pavlik V, Darby E, Doody R. Factors that influence survival in Alzheimer's patients. Alzheimers Dement. 2011;7(4 Suppl):S513.
  • Doody R, Chan W, Pavlik V, Massman P, Darby E, Rountree S, et al. Age at onset and pre- morbid IQ influence early progression rates in AD. Neurology. 2009;72(11 Suppl 3):A478. [View poster]
  • Rountree S, Pavlik V, Chan W, Doody RS. Persistent antidementia drug treatment and survival in an Alzheimer's disease (AD) cohort. Alzheimer's & Dementia. 2008;4(4 Suppl):T698-9. [View poster]
  • Pavlik VN, Doody RS, Rountree SD, Darby EJ. Vitamin E use is associated with improved survival in an AD cohort. Neurology. 2008;70(11 Suppl 1):A146. [View poster]
  • Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Gulley A, et al. Exposure to anti-dementia drugs slows clinical progression of Alzheimer's disease (AD). Ann Neurol. 2007;62 Suppl 11:S55. [View poster]
  • Rountree SD, Pavlik VN, Chan W, Darby EJ, Doody RS. Clinical factors associated with the preprogression rate (PPR) in Alzheimer's disease (AD). Alzheimer's & Dementia. 2007;3(3 Suppl):S130. [View poster]
  • Sitburana O, Rountree S, Vuong KD, Ondo W . Weight change in parkinson and alzheimer patients taking atypical antipsychotic drugs. Mov Disord. 2007;22 Suppl 16:S190. [View poster]
  • Doody R, Pavlik V, Massman P, Rountree S, Waring S, Darby E, et al. Predicting progression and survival in Alzheimer's disease. Alzheimer's & Dementia. 2006;2(3 Suppl):S83.

E-mail this page to a friend